Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Yangonin is a natural kavalactone derived from the kava plant, Piper methysticum. It is one of the six major kavalactones, which are the active constituents of the plant. Yangonin has the ability to enhance the binding of bicuculline at the γ-amino butyric acid (GABA) receptor GABAA at 1.0 μM and also binds to the central cannabinoid (CB1) receptor with a Ki value of 0.72 μM. Additionally, it has been found to block the activation of NF-κB by TNF-α and inhibit the growth of bladder cancer cell lines through the induction of autophagic cell death.

500-62-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 500-62-9 Structure
  • Basic information

    1. Product Name: YANGONIN
    2. Synonyms: YANGONIN;11-METHOXYYANGONIN;4-methoxy-6-(beta-(p-anisyl)vinyl)-alpha-pyrone;4-methoxy-6-(p-methoxystyryl)-2h-pyran-2-on;4-methoxy-6-(p-methoxystyryl)-2h-pyran-2-one;5-hydroxy-3-methoxy-7-(p-methoxyphenyl)-2,4,6-heptatrienoicacidgamma-lacton;4-Methoxy-6-[2-(4-methoxyphenyl)ethenyl]-2H-pyran-2-one;4-Methoxy-6-[(E)-2-(4-methoxyphenyl)vinyl]-2H-pyran-2-one
    3. CAS NO:500-62-9
    4. Molecular Formula: C15H14O4
    5. Molecular Weight: 258.27
    6. EINECS: N/A
    7. Product Categories: Aromatics;Heterocycles;Mutagenesis Research Chemicals
    8. Mol File: 500-62-9.mol
  • Chemical Properties

    1. Melting Point: 155-157°
    2. Boiling Point: 487.6 °C at 760 mmHg
    3. Flash Point: 219.8 °C
    4. Appearance: pale yellow powder
    5. Density: 1.2 g/cm3
    6. Vapor Pressure: 1.18E-09mmHg at 25°C
    7. Refractive Index: 1.577
    8. Storage Temp.: 2-8°C
    9. Solubility: Chloroform (Slightly), Methanol (Slightly)
    10. Stability: Light Sensitive
    11. BRN: 230710
    12. CAS DataBase Reference: YANGONIN(CAS DataBase Reference)
    13. NIST Chemistry Reference: YANGONIN(500-62-9)
    14. EPA Substance Registry System: YANGONIN(500-62-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 500-62-9(Hazardous Substances Data)

500-62-9 Usage

Uses

Used in Pharmaceutical Industry:
Yangonin is used as an anxiolytic agent for the treatment of anxiety disorders. It is found in kava beverages and other preparations that have been traditionally used to alleviate anxiety and stress.
Used in Cancer Research:
Yangonin is used in cancer research as it has been shown to inhibit the growth of bladder cancer cell lines through the induction of autophagic cell death, with IC50 values ranging from 15-59 mg/mL.
Used in Neuropharmacology:
Yangonin is used in neuropharmacological research due to its ability to enhance the binding of bicuculline at the GABAA receptor, which plays a crucial role in the regulation of neuronal excitability and has potential implications for the treatment of neurological disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 500-62-9 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,0 and 0 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 500-62:
(5*5)+(4*0)+(3*0)+(2*6)+(1*2)=39
39 % 10 = 9
So 500-62-9 is a valid CAS Registry Number.
InChI:InChI=1/C15H14O4/c1-17-12-6-3-11(4-7-12)5-8-13-9-14(18-2)10-15(16)19-13/h3-10H,1-2H3/b8-5+

500-62-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (75575)  Yangonin  analytical standard

  • 500-62-9

  • 75575-5MG

  • 5,093.01CNY

  • Detail

500-62-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name YANGONIN

1.2 Other means of identification

Product number -
Other names 4-Methoxy-6-((E)-4-methoxystyryl)pyran-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:500-62-9 SDS

500-62-9Synthetic route

4-methoxy-6-vinyl-2H-pyran-2-one
1334928-11-8

4-methoxy-6-vinyl-2H-pyran-2-one

4-methoxybenzenediazonium tetrafluoroborate
459-64-3

4-methoxybenzenediazonium tetrafluoroborate

yangonin
500-62-9

yangonin

Conditions
ConditionsYield
Stage #1: 4-methoxy-6-vinyl-2H-pyran-2-one With sodium acetate; palladium diacetate In acetonitrile for 0.166667h; Heck-Matsuda reaction;
Stage #2: 4-methoxybenzenediazonium tetrafluoroborate In acetonitrile Heck-Matsuda reaction;
96%
(4-Methoxy-2-oxo-2H-pyran-6-yl)methyltriphenylphosphonium Bromide
54108-46-2

(4-Methoxy-2-oxo-2H-pyran-6-yl)methyltriphenylphosphonium Bromide

4-methoxy-benzaldehyde
123-11-5

4-methoxy-benzaldehyde

yangonin
500-62-9

yangonin

Conditions
ConditionsYield
With sodium ethanolate In ethanol; N,N-dimethyl-formamide for 16h; Ambient temperature;95%
(E)-4-methoxy-6-(4-methoxystyryl)-5,6-dihydro-2H-pyran-2-one
3155-49-5, 3328-60-7, 62445-12-9, 130464-78-7

(E)-4-methoxy-6-(4-methoxystyryl)-5,6-dihydro-2H-pyran-2-one

yangonin
500-62-9

yangonin

Conditions
ConditionsYield
With 2,3-dicyano-5,6-dichloro-p-benzoquinone In benzene for 2h; Inert atmosphere; Reflux;85%
With 2,3-dicyano-5,6-dichloro-p-benzoquinone In toluene for 2h; Inert atmosphere; Reflux;85%
With 2,3-dicyano-5,6-dichloro-p-benzoquinone In benzene for 2h; Reflux;80%
With 2,3-dicyano-5,6-dichloro-p-benzoquinone In tetrahydrofuran for 0.5h; Reflux;303.5 mg
4-hydroxy-6-(4-methoxy-styryl)-pyran-2-one
361433-25-2

4-hydroxy-6-(4-methoxy-styryl)-pyran-2-one

dimethyl sulfate
77-78-1

dimethyl sulfate

yangonin
500-62-9

yangonin

Conditions
ConditionsYield
With triisopropylamine In dichloromethane at -78 - 20℃; for 2h;65%
4-methoxy-6-methyl-2H-pyran-2-one
672-89-9

4-methoxy-6-methyl-2H-pyran-2-one

4-methoxy-benzaldehyde
123-11-5

4-methoxy-benzaldehyde

yangonin
500-62-9

yangonin

Conditions
ConditionsYield
With potassium tert-butylate In N,N-dimethyl-formamide at 25℃; for 48h; Aldol Condensation;61%
With magnesium methanolate Inert atmosphere; Reflux;59%
With magnesium In methanol for 4h; Reflux;30%
6-(4-methoxy-trans-styryl)-pyran-2,4-dione
501-57-5

6-(4-methoxy-trans-styryl)-pyran-2,4-dione

A

2-methoxy-6-<2-(4-methoxyphenyl)ethenyl>pyran-4-one
101-35-9

2-methoxy-6-<2-(4-methoxyphenyl)ethenyl>pyran-4-one

B

yangonin
500-62-9

yangonin

Conditions
ConditionsYield
With diethyl ether
4-hydroxy-6-(4-methoxy-styryl)-pyran-2-one
361433-25-2

4-hydroxy-6-(4-methoxy-styryl)-pyran-2-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide for 18h; Ambient temperature; Yield given;
4-methoxy-benzenediazonium-(1)-chloride-solution

4-methoxy-benzenediazonium-(1)-chloride-solution

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) COCl2, 2.) triethylamine / 1.) RT, 18 h, 2.) petroleum ether, CH2Cl2, 0 deg C, 30 min
2: 53 percent / 60 percent NaH, 1.46 M n-BuLi / tetrahydrofuran; hexane / 20 min, rt; 0 deg C, 10 min; 0 deg C, 1-2 h
3: 1.) TFA, 2.) acetic anhydride / 1.) CH2Cl2, rt, 1 h, 2.) rt, 18 h
4: K2CO3 / dimethylformamide / 18 h / Ambient temperature
View Scheme
yangonin

yangonin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 53 percent / 60 percent NaH, 1.46 M n-BuLi / tetrahydrofuran; hexane / 20 min, rt; 0 deg C, 10 min; 0 deg C, 1-2 h
2: 1.) TFA, 2.) acetic anhydride / 1.) CH2Cl2, rt, 1 h, 2.) rt, 18 h
3: K2CO3 / dimethylformamide / 18 h / Ambient temperature
View Scheme
(E)-tert-butyl 3,5-dioxo-7-(p-methoxyphenyl)hept-6-enoate
157287-08-6

(E)-tert-butyl 3,5-dioxo-7-(p-methoxyphenyl)hept-6-enoate

yangonin
500-62-9

yangonin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) TFA, 2.) acetic anhydride / 1.) CH2Cl2, rt, 1 h, 2.) rt, 18 h
2: K2CO3 / dimethylformamide / 18 h / Ambient temperature
View Scheme
6-(bromomethyl)-4-methyl-2H-pyran-2-one
54108-45-1

6-(bromomethyl)-4-methyl-2H-pyran-2-one

yangonin
500-62-9

yangonin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 92 percent / benzene / 16 h / Heating
2: 95 percent / sodium ethoxide / dimethylformamide; ethanol / 16 h / Ambient temperature
View Scheme
4-hydroxy-6-methyl-2-pyron
675-10-5

4-hydroxy-6-methyl-2-pyron

yangonin
500-62-9

yangonin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: potassium carbonate / acetone / Inert atmosphere; Reflux
2: selenium(IV) oxide / 1,4-dioxane / 5 h / 180 °C / Inert atmosphere; Sealed tube
3: n-butyllithium; methyl-triphenylphosphonium iodide / tetrahydrofuran / 3 h / -78 - 20 °C / Inert atmosphere
4: sodium acetate; palladium diacetate / acetonitrile / 0.17 h
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate / dimethyl sulfoxide / 20 °C
2: magnesium methanolate / methanol / 60 °C
View Scheme
Multi-step reaction with 2 steps
1: potassium carbonate / acetone / 20 °C
2: magnesium methanolate / Inert atmosphere; Reflux
View Scheme
4-methoxy-6-methyl-2H-pyran-2-one
672-89-9

4-methoxy-6-methyl-2H-pyran-2-one

yangonin
500-62-9

yangonin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: selenium(IV) oxide / 1,4-dioxane / 5 h / 180 °C / Inert atmosphere; Sealed tube
2: n-butyllithium; methyl-triphenylphosphonium iodide / tetrahydrofuran / 3 h / -78 - 20 °C / Inert atmosphere
3: sodium acetate; palladium diacetate / acetonitrile / 0.17 h
View Scheme
4-methoxy-6-vinyl-5,6-dihydro-2H-pyran-2-one
1092383-57-7

4-methoxy-6-vinyl-5,6-dihydro-2H-pyran-2-one

yangonin
500-62-9

yangonin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Pd2(dba)4; sodium acetate / 1 h / 80 °C / Microwave irradiation
2: 2,3-dicyano-5,6-dichloro-p-benzoquinone / toluene / 2 h / Inert atmosphere; Reflux
View Scheme

500-62-9Relevant articles and documents

Synthetic kavalactone analogues with increased potency and selective anthelmintic activity against larvae of haemonchus contortus in vitro

Chang, Bill C. H.,Dilrukshi Herath, H. M. P.,Garcia-Bustos, José,Gasser, Robin B.,Hofmann, Andreas,Jabbar, Abdul,Ma, Guangxu,Nguyen, Nghi,Sleebs, Brad E.,Taki, Aya C.,Wang, Tao

supporting information, (2020/04/30)

Kava extract, an aqueous rhizome emulsion of the plant Piper methysticum, has been used for centuries by Pacific Islanders as a ceremonial beverage, and has been sold as an anxiolytic agent for some decades. Kavalactones are a major constituent of kava extract. In a previous investigation, we had identified three kavalactones that inhibit larval development of Haemonchus contortus in an in vitro-bioassay. In the present study, we synthesized two kavalactones, desmethoxyyangonin and yangonin, as well as 17 analogues thereof, and evaluated their anthelmintic activities using the same bioassay as employed previously. Structure activity relationship (SAR) studies showed that a 4-substituent on the pendant aryl ring was required for activity. In particular, compounds with 4-trifluoromethoxy, 4-difluoromethoxy, 4-phenoxy, and 4-N-morpholine substitutions had anthelmintic activities (IC50 values in the range of 1.9 to 8.9 μM) that were greater than either of the parent natural products-desmethoxyyangonin (IC50 of 37.1 μM) and yangonin (IC50 of 15.0 μM). The synthesized analogues did not exhibit toxicity on HepG2 human hepatoma cells in vitro at concentrations of up to 40 μM. These findings confirm the previously-identified kavalactone scaffold as a promising chemotype for new anthelmintics and provide a basis for a detailed SAR investigation focused on developing a novel anthelmintic agent.

Design, syntheses and lipid accumulation inhibitory activities of novel resveratrol mimics

Li, Chanjuan,Cheng, Bao,Fang, Sai,Zhou, Huihao,Gu, Qiong,Xu, Jun

, p. 114 - 122 (2017/11/27)

Hispidine was initially discovered from Ficus Hispida for cardiovascular protection. In this paper, hispidine derivatives, which contain a novel resveratrol-like scaffold, have been designed, synthesized, and assayed as agents against lipid accumulations in 3T3-L1 pre-adipocytes. Six hispidine derivatives have the activity of reducing TG in 3T3-L1 adipocytes in dosage-dependent manner. The most active compound can reduce the lipid accumulation up to 78.4% at 10 μM qPCR and Western blotting results demonstrate that the two most active compounds inhibit both lipodenesis and adipogenesis in 3T3-L1 cells through (1) increasing the phosphorylations of AMPK and ACC, promoting SIRT1 expression. These three proteins are key regulators for lipogenesis and energy metabolism. (2) Decreasing the expressions of PPARγ, sREBP-1c, and FABP4, which are pivotal regulators for adipogenesis. Overall, this work proves that hispidine derivatives diminish the lipid accumulation in 3T3-L1 cell line by downregulating lipogenic and adipogenic pathways.

Iterative polyketide synthesis via a consecutive carbonyl-protecting strategy

Akagawa, Kengo,Kudo, Kazuaki

, p. 4279 - 4285 (2018/04/14)

To address the difficulty in protecting a β-polycarbonyl compound, a method for the sequential protection of elongating carbonyl groups was demonstrated. The iterative chain elongation of a carboxylic acid with malonic acid half thioester followed by the protection of the resulting β-ketothioester was performed via the stepwise formation of an isoxazole ring using an O-protected oxime functionality. Yangonin and isosakuranetin were synthesized according to this procedure.

BONE METABOLISM IMPROVER

-

Paragraph 0055, (2018/09/26)

PROBLEM TO BE SOLVED: To provide an agent and food/drink having osteoclast differentiation inhibitory action and osteoblast differentiation promoting action and useful against osteoporosis. SOLUTION: The present invention provides an osteoblast differentiation promoter or osteoclast differentiation inhibitor containing a kawalactone derivative compound as an active ingredient, and an agent for preventing or improving osteoporosis or rheumatoid arthritis that contains the same. SELECTED DRAWING: None COPYRIGHT: (C)2018,JPOandINPIT

Synthesis of novel 5,6-dehydrokawain analogs as osteogenic inducers and their action mechanisms

Kumagai, Momochika,Nishikawa, Keisuke,Mishima, Takashi,Yoshida, Izumi,Ide, Masahiro,Koizumi, Keiko,Nakamura, Munetomo,Morimoto, Yoshiki

, p. 2401 - 2406 (2017/05/09)

An imbalance between bone resorption by osteoclasts and bone formation by osteoblasts can cause bone loss and bone-related disease. In a previous search for natural products that increase osteogenic activity, we found that 5,6-dehydrokawain (1) from Alpinia zerumbet promotes osteoblastogenesis. In this study, we synthesized and evaluated series of 5,6-dehydrokawain analogs. Our structure-activity relationships revealed that alkylation of para or meta position of aromatic ring of 1 promote osteogenic activity. Among the potential analogs we synthesized, (E)-6-(4-Ethylstyryl)-4-methoxy-2H-pyran-2-one (14) and (E)-6-(4-Butylstyryl)-4-methoxy-2H-pyran-2-one (21) both significantly up-regulated Runx2 and Osterix mRNA expression at 10?μM. These osteogenic activities could be mediated by bone morphogenetic protein (BMP) and activation of p38 MAPK signaling pathways. Compounds 14 and 21 also inhibited RANKL-induced osteoclast differentiation of RAW264 cells. These results indicated that novel 5,6-dehydrokawain analogs not only increase osteogenic activity but also inhibit osteoclast differentiation, and could be potential lead compounds for the development of anti-osteoporosis agents.

An improved aldol protocol for the preparation of 6-styrenylpyrones

Kraus, George A.,Wanninayake, Umayangani K.

, p. 7112 - 7114 (2015/12/01)

An improved aldol protocol for the synthesis of 6-styrenylpyrones is reported. The first synthesis of PTP1B inhibitor 1 and 4 has been described.

The Chemical Basis of Fungal Bioluminescence

Purtov, Konstantin V.,Petushkov, Valentin N.,Baranov, Mikhail S.,Mineev, Konstantin S.,Rodionova, Natalja S.,Kaskova, Zinaida M.,Tsarkova, Aleksandra S.,Petunin, Alexei I.,Bondar, Vladimir S.,Rodicheva, Emma K.,Medvedeva, Svetlana E.,Oba, Yuichi,Oba, Yumiko,Arseniev, Alexander S.,Lukyanov, Sergey,Gitelson, Josef I.,Yampolsky, Ilia V.

supporting information, p. 8124 - 8128 (2015/07/07)

Many species of fungi naturally produce light, a phenomenon known as bioluminescence, however, the fungal substrates used in the chemical reactions that produce light have not been reported. We identified the fungal compound luciferin 3-hydroxyhispidin, which is biosynthesized by oxidation of the precursor hispidin, a known fungal and plant secondary metabolite. The fungal luciferin does not share structural similarity with the other eight known luciferins. Furthermore, it was shown that 3-hydroxyhispidin leads to bioluminescence in extracts from four diverse genera of luminous fungi, thus suggesting a common biochemical mechanism for fungal bioluminescence.

A rapid and diverse construction of 6-substituted-5,6-dihydro-4-hydroxy-2- pyrones through double Reformatsky reaction

Mineno, Masahiro,Sawai, Yasuhiro,Kanno, Kazuaki,Sawada, Naotaka,Mizufune, Hideya

, p. 10921 - 10926 (2014/01/06)

A rapid and diverse synthesis of biologically important 6-substituted-5,6-dihydro-4-hydroxy-2-pyrones through a double Reformatsky reaction of aldehydes to δ-hydroxy-β-ketoesters followed by lactonization is described. Due to the high functional group tolerance and reaction site discrimination between aldehyde, nitrile, and ester groups in the substrate, the protocol can provide the dihydropyrones with bromo, nitro, carboxylic acid, and β-ketoester groups, which are suitable for the further derivatizations. Furthermore, the protocol has been successfully applied to the rapid total synthesis of naturally occurring Yangonin.

Heck-matsuda arylation as a strategy to access kavalactones isolated from polygala sabulosa, piper methysticum, and analogues

Soldi, Cristian,Moro, Angelica V.,Pizzolatti, Moacir G.,Correia, Carlos R. D.

experimental part, p. 3607 - 3616 (2012/07/31)

Herein, we describe the total syntheses of three bioactive pyrones isolated from Polygala sabulosa (i.e., 1, 4, and 7) and eight isolated from Piper methysticum (i.e., 8-10, 13, 15, and 18-20) using the Heck-Matsuda arylation as the key strategy. The evaluation of this methodology by employing different arenediazonium tetrafluoroborates revealed that the Heck arylation was more efficient when the olefin undergoing arylation possessed the vinyl-2-pyrone structural unit instead of the vinyl dihydro-2-pyrone moiety. The Heck-Matsuda arylation of many of the examined olefins proceeded in a practical manner with total regio- and stereocontrol.

Composition for Topical Use

-

, (2010/12/31)

The use, as a dermatological or cosmetic medicament, of compounds capable of transiently interacting with the AhR receptor (aryl hydrocarbon receptor) as agents for modulating skin functions such as sebaceous function, skin healing, skin atrophy termed “dermatoporosis”, estrogen deprivation and defense against infection, without inducing other toxic effects of the TCDD type. The compounds that interact with the AhR receptor are chosen in that they have a metabolism favorable to the dissociation of these effects, in particular by virtue of in situ production from a precursor and/or metabolization modulated in situ.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 500-62-9